TY - JOUR T1 - Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients JF - Gut JO - Gut SP - 182 LP - 184 DO - 10.1136/gutjnl-2012-302656 VL - 62 IS - 1 AU - Quan Yuan AU - Liu-Wei Song AU - Chun-Jen Liu AU - Zhuo Li AU - Ping-Guo Liu AU - Cheng-Hao Huang AU - Yan Yan AU - Sheng-Xiang Ge AU - Ying-Bin Wang AU - Cheng-Yuan Peng AU - Jun Zhang AU - Jia-Horng Kao AU - Ding-Shinn Chen AU - Pei-Jer Chen AU - Ning-Shao Xia Y1 - 2013/01/01 UR - http://gut.bmj.com/content/62/1/182.2.abstract N2 - We read with interest the recent article by Dandri emphasising the use of novel quantitative biomarkers as tools for predicting treatment response and disease progression in chronic hepatitis B infection (CHB).1 The authors carried out a comprehensive review of the clinical implications of quantitative measurement of viral biomarkers both in blood and in liver, such as: serum HBsAg, serum HBeAg and intrahepatic cccDNA, based on current knowledge.1 In addition to these, … ER -